FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps

FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps

The U.S. Food and Drug Administration is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks and recommends that patients using these models switch their insulin pump to models that are better equipped to protect against these potential risks. To date, the FDA is not aware of any confirmed reports of patient harm related to these potential cybersecurity risks. The potential risks are related to the wireless communication between Medtronic's MiniMed insulin pumps and other devices such as blood glucose meters, continuous glucose monitoring systems, the remote controller and CareLink USB device used with these pumps. The FDA is concerned that, due to ...

Read More